Keyphrases
Photobiomodulation
100%
Cardiovascular Aging
100%
Photobiomodulation Therapy
100%
TGF-1
42%
Age-associated
42%
Early Treatment
28%
Genotype
28%
Treatment Duration
28%
Neuromuscular Coordination
28%
Cardiac Function
14%
Left Ventricular Ejection Fraction
14%
Hypertension
14%
Mouse Model
14%
Human Studies
14%
Overexpressing
14%
Transgenic Mice
14%
Albert Einstein
14%
Left Ventricular Mass
14%
Littermate
14%
Clinical Translation
14%
Daily Exposure
14%
Total Dose
14%
Light Therapy
14%
Cardiovascular Changes
14%
Gait Analysis
14%
Near-infrared Light
14%
Serial Echocardiography
14%
Left Ventricular End-diastolic Volume (LVEDV)
14%
Experimental Animal Models
14%
Left Atrial Dimension
14%
Cumulative Survival Rate
14%
Adenylyl Cyclase 8
14%
Anti-aging
14%
Dose Optimization
14%
Optimization Study
14%
Aortic Wall Stiffness
14%
Cardiac Aging
14%
Gait Symmetry
14%
Cardiovascular Remodeling
14%
Age-associated Chronic Diseases
14%
COVID-19 Restrictions
14%
Medicine and Dentistry
Cardiovascular System
100%
Heart Function
33%
Heart Left Ventricle Ejection Fraction
33%
Echocardiography
33%
Atherosclerosis
33%
Human Study
33%
Chronic Disease
33%
Transgenic Mouse
33%
End-Diastolic Volume
33%
Low Drug Dose
33%
Adenylate Cyclase
33%
Arterial Stiffness
33%
Phototherapy
33%
Defibrotide
33%
Gait
33%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse
100%
Mouse Model
50%
Atherosclerosis
50%
Human Study
50%
Chronic Disease
50%
Adenylate Cyclase
50%
Transgenic Mouse
50%
Experimental Animal
50%
Defibrotide
50%
Neuroscience
Neuromuscular
100%
Adenylyl Cyclase
50%
End-Diastolic Volume
50%
Light Therapy
50%
Gait Analysis
50%
Defibrotide
50%
Biochemistry, Genetics and Molecular Biology
Photobiomodulation
100%
Mouse
18%
Heart Left Ventricle Ejection Fraction
9%
Animal Model
9%
Low Drug Dose
9%
Wild Type
9%
Mouse Model
9%
Heart Function
9%
Adenylate Cyclase
9%
Infrared Radiation
9%
Transgenic Mouse
9%
Experimental Animal
9%
Arterial Stiffness
9%
Human Study
9%
Heart Left Ventricle Mass
9%
Gait
9%